| 1/24/2019 | BKCVHY | S&P puts Actuant on watch
|
| 4/30/2012 | CVHYLM | Actuant accepts $228.66 million of 6 7/8% notes, redeems convertibles
|
| 4/4/2012 | BKCVHY | S&P rates Actuant notes BB
|
| 4/2/2012 | BKCVHY | Moody's rates Actuant notes Ba2
|
| 3/29/2012 | CVLM | Actuant announces redemption of all $117.59 million of 2% convertibles
|
| 3/28/2012 | CV | Market Commentary: Amylin adds on word of Bristol-Myers offer; Actuant down on hedge on call; Synnex mixed
|
| 3/27/2012 | BKCVHY | S&P upgrades Actuant to BB+
|
| 11/23/2011 | CVHY | S&P: Actuant to positive
|
| 11/16/2011 | CV | Actuant says no contingent interest on tap for convertibles due 2023
|
| 7/29/2011 | BKCVHY | Moody's cuts Actuant notes
|
| 5/16/2011 | CV | Actuant sets six-month contingent interest for convertibles due 2023
|
| 12/16/2010 | CVLM | Actuant says less than $100,000 of 2% convertibles due 2023 put back
|
| 4/14/2010 | CV | Market Commentary: Popular convertibles, stock rise; Intel, Linear strengthen on earnings; MGM Mirage on tap
|
| 2/8/2010 | CV | Market Commentary: Airline convertibles higher in trade; Actuant active; Tyson quiet; Annaly Capital to price
|
| 7/24/2009 | CV | Market Commentary: Intel eyed as volume name; Ingersoll-Rand, Actuant strong; Human Genome gains more; Medarex over par
|
| 7/16/2009 | BKCVDDHY | S&P affirms Actuant
|
| 6/23/2009 | CV | Market Commentary: Rambus up in gray, deal seen cheap; Alliance One, LodgeNet quiet; Actuant gains as stock dips
|
| 6/17/2009 | BKBWCVHY | Actuant uses third-quarter free cash flow of $65 million to trim debt
|
| 2/26/2009 | BKCVHY | S&P: Actuant outlook negative
|
| 9/22/2008 | BKCVHY | Moody's cuts Actuant outlook to stable
|
| 6/4/2007 | BKCV | S&P assigns Actuant notes BB-
|
| 6/4/2007 | BKCV | Moody's rates Actuant notes Ba2
|
| 9/28/2006 | BKCV | Moody's introduces new ratings
|
| 6/20/2006 | CV | Market Commentary: Medtronic, Amgen fall prey to selling pressure; JetBlue adds; Actuant plunges
|
| 7/15/2005 | CVHY | Actuant files $900 million shelf
|
| 4/15/2005 | BKCVHY | S&P: Actuant unaffected
|
| 2/8/2005 | BKCVHY | S&P affirms Actuant
|
| 12/31/2004 | BKCVHY | S&P: Actuant still on watch
|
| 11/22/2004 | BKCVHY | S&P: Actuant on watch
|
| 11/10/2004 | BKCVHY | S&P: Actuant up to positive
|
| 8/30/2004 | CVHY | Actuant to defease 13% notes, remove guarantees on convertibles
|
| 8/19/2004 | BKCVHY | Moody's ups Actuant, rates loan Ba2
|
| 5/3/2004 | BKCVHY | S&P rates Actuant revolver BB
|
| 11/21/2003 | BKCVHY | S&P rates new Actuant convertible B+
|
| 11/21/2003 | CV | Market Commentary: New paper mixed with thin trading; Lincare, Apria lose on Medicare reform worries
|
| 11/11/2003 | CV | Market Commentary: EchoStar gets ditched, sell-off takes 2.75 points on pressured outlook; 3 new deals emerge
|
| 11/7/2003 | CV | Actuant greenshoe exercised, raising convertibles to $150 million
|
| 11/5/2003 | CV | New Issue: Actuant upsized $125 million convertible at 2.0%, up 35%
|
| 11/5/2003 | CV | Market Commentary: Actuant trades pat with gray market at 102; Amkor tracks another 1 to 2 points higher
|
| 11/4/2003 | CV | Actuant prices $125 million to yield 2%, up 35%
|
| 11/4/2003 | CV | Market Commentary: Navigant trades north of 107 on lack of supply; Actuant up 2 points in gray market action
|
| 11/3/2003 | CV | Market Commentary: American Tower gains 2.25 points on junk bond deal; three small new deals emerge
|
| 11/3/2003 | CV | Actuant $100 million convertible talked at 2.0-2.5% yield, up 30-35%
|
